Treatment of acute retinal necrosis syndrome

Drugs of Today

Volumn 42, Issue 8, 2006, Pages 545-551

  Aizman, Alexander ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACICLOVIR; ACICLOVIR TRIPHOSPHATE; ANTICOAGULANT AGENT; ANTIVIRUS AGENT; CORTICOSTEROID; CREATININE; FAMCICLOVIR; FOSCARNET; GANCICLOVIR; PENCICLOVIR; PREDNISOLONE; STEROID; VALACICLOVIR; VALGANCICLOVIR;

ABDOMINAL PAIN; ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ACUTE KIDNEY TUBULE NECROSIS; ANEMIA; AREA UNDER THE CURVE; ARTICLE; BONE MARROW SUPPRESSION; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; COMA; CONVULSION; CREATININE BLOOD LEVEL; DIARRHEA; DOSE RESPONSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG ERUPTION; DRUG MECHANISM; DRUG TOLERABILITY; GASTROINTESTINAL SYMPTOM; GLOMERULOPATHY; HALF LIFE TIME; HEADACHE; HUMAN; HYPOCALCEMIA; INTERSTITIAL NEPHRITIS; IRRITABILITY; KIDNEY DISEASE; KIDNEY FAILURE; KIRISAWA UVEITIS; LASER COAGULATION; NAUSEA; NEPHROTOXICITY; NEUROTOXICITY; NEUTROPENIA; REPRODUCTIVE TOXICITY; RETINA SURGERY; RETINITIS; SIDE EFFECT; THROMBOCYTOPENIA; TREMOR; UNSPECIFIED SIDE EFFECT; UROLITHIASIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIVIRAL AGENTS; HUMANS; LASER SURGERY; LIGHT COAGULATION; OPHTHALMOLOGIC SURGICAL PROCEDURES; RETINAL NECROSIS SYNDROME, ACUTE; STEROIDS;

EID: 33749378226     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.2006.42.8.1021519     Document Type: Article

References (38)

1. Figueroa, M.S., Garabito, I., Gutierrez, C. et al. Famciclovir for the treatment of Acute Retinal Necrosis (ARN) syndrome. Am J Ophthalmol 1997, 123: 255-6.
2. Aslanides, I.M., De Souza, S., Wong, D. et al. Oral valacyclovir in the treatment of acute retinal necrosis syndrome. Retina 2002, 22: 352-4.
3. Savant, V., Saeed, T., Denniston, A., Murray, P.I. Oral valganciclovir treatment of varicella zoster virus acute retinal necrosis. Eye 2004, 18: 544-5.
4. Guex-Crosier, Y., Meylan, P.R. High dosage of oral valacyclovir as an alternative treatment of varicella zoster acute retinal necrosis. Eye 2006, 20: 247.
5. Silverstein, B., Conrad, D., Margolis, T. et al. Cytomegalovirus- associated acute retinal necrosis syndrome. Am J Ophthalmol 1997, 123: 257-8.
6. Long, H.M, Dick, A. Presumed CMV associated necrotizing retinopathy in a non-HIV immunocompromised host. Clin Experiment Ophthalmol 2005, 33: 330-2.
7. Kramer, S., Brummer, C., Zierhut, M. Epstein-Barr virus associated acute retinal necrosis. Br J Ophthalmol 2001, 85: 114.
8. Urayama, A., Yamada, N., Sasaki, T. et al. Unilateral acute uveitis with periarteritis and detachment. Jpn J Clin Ophthalmol 1971, 25: 607-19.
9. Culbertson, W.W., Blumenkranz, M.S., Haines, H. et al. The acute retinal necrosis syndrome. II. Histopathology and etiology. Ophthalmology 1982, 89: 1317-25.
10. Culbertson, W.W., Blumenkranz, M.S., Pepose, U.S. et al. Varicella zoster virus is a cause of the acute retinal necrosis syndrome. Ophthalmology 1986, 93: 559-69.
11. Nussenblatt, R.B., Whitcup, S.M. Acute retinal necrosis. In: Uveitis: Fundamentals and Clinical Practice, 3rd ed. Mosby, Philadelphia 2004, 201-2.
12. Holland, G.N., Cornell, P.J., Park, M.S. et al. An association between acute retinal necrosis syndrome and HLA-DQw7 and phenotype Bw62, DR4. Am J Ophthalmol 1989, 108: 370-4.
13. Holland, G.N., Executive Committee of the American Uveitis Society. Standard diagnostic criteria for the acute retinal necrosis syndrome. Am J Ophthalmol 1994, 117: 663-7.
14. Duker, J.S., Blumenkranz, M.S. Diagnosis and management of the Acute Retinal Necrosis (ARN) syndrome. Surv Ophthamol 1991, 35: 327-43.
15. Blumenkranz, M.S., Culbertson, W.W., Clarkson, J.G. et al. Treatment of the acute retinal necrosis syndrome with intravenous acyclovir. Ophthalmology 1986, 93: 296-300.
16. Goodman & Gilman's. The Pharmacological Basis of Therapeutics, 9th ed. 1996, 1196-202.
17. Keatings, M.R. Antiviral agents. Mayo Clin Proc 1992, 67: 160-78.
18. Palay, D.A., Sternberg, P., Davis, J. et al. Decrease in the risk of bilateral acute retinal necrosis by acyclovir therapy. Am J Ophthalmol 1991, 112: 250-5.
19. Crapotta, J.A., Freeman, W.R., Feldman, R.M. Visual outcome in acute retinal necrosis. Retina 1993, 13: 208-13.
20. Rolston, K., Manzullo, E., Elting, L. et al. Ambulatory management of varicella-zoster virus infection in immunocompromised cancer patients. Supportive Care Cancer 1998, 6: 57-62.
21. Wang, L., Schultz, S., Weller, L. et al. Pharmacokinetics and safety of valacyclovir, an acyclovir prodrug, in geriatric volunteers with and without concomitant diuretic therapy. J Am Geriatr Soc 1993, 41 (Suppl. 10): SA23.
22. Soul-Lawton, J., Seaber, N., Wootton, P. et al. Absolute bioavailability and metabolic disposition of valacyclovir, the L-valyl ester of acyclovir, following oral administration to humans. Antimicrob Agents Chemother 1995, 39: 2759-64.
23. Acosta, E., Fletcher, C. Valacyclovir. Ann Pharmacother 1997, 31: 185-91.
24. Grant, D.M., Mauskopf, J.A., Bell, L. et al. Comparison of valacyclovir and acyclovir for the treatment of herpes zoster in immunocompetent patients over 50 years of age: A cost-consequence model. Pharmacotherapy 1997, 17: 333-41.
25. Weller, S., Blum, M., Doucette, T.C. et al. Pharmacokinetics of the acyclovir prodrug valacyclovir after escalating single- and multiple-dose administration to normal volunteers. Clin Pharmacol Ther 1993, 54: 595-605.
26. Hoglund, M., Ljungman, P., Weller, S. Comparable acyclovir exposures produced by oral valaciclovir and intravenous acyclovir in immunocompromised cancer patients. J Antimicrob Chemother 2001, 47: 855-61.
27. Beutner, K., Friedman, D., Forszpaniak, C. et al. Valacyclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob Agents Chemother 1995, 39: 1546-53.
28. Lycke, J., Malmestrom, C., Stahle, L. Acyclovir levels in serum and cerebrospinal fluid after oral administration of valacyclovir. Antimicrob Agents Chemother 2003, 47: 2438-41.
29. Vere Hodge, R.A. Famciclovir and penciclovir: The mode of action of famciclovir including its conversion to penciclovir. Antiviral Chem Chemother 1993, 4: 67-84.
30. Holland, G.N., Buhles, W.C. Jr., Mastre, B. et al. A controlled retrospective study of ganciclovir treatment for cytomegalovirus retinopathy. Arch Ophthalmol 1989, 107: 1759-66.
31. Martin, D.F., Sierra-Madero, J., Walmsley, S. et al. A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis. N Engl J Med 2002, 346: 1119-26.
32. Tran, T.H., Bodaghi, B., Rozenberg, F., Cassoux, N., Fardean, C., LeHoang, P. Viral cause and management of necrotizing herpetic retinopathies. J Fr Ophthalmol 2004, 27: 223-36.
33. Khurana, R.N., Charonis, A., Samuel, M.A., Gupta, A., Tawansy, K.A. Intravenous foscarnet in the management of acyclovir-resistant herpes simplex virus type 2 in acute retinal necrosis in children. Med Sci Monit 2005, 11: CS75-8.
34. Ando, F., Kato, M., Goto, S. et al. Platelet function in bilateral acute retinal necrosis. Am J Ophthalmol 1983, 96: 27-32.
35. Morse, L.S., Mizoguchi, M. Diagnosis and management of viral retinitis in the acute retinal necrosis syndrome. Semin Ophthalmol 1995, 10: 28-41.
36. Bonfioli, A.A., Eller, A.W. Acute retinal necrosis. Semin Ophthalmol 2005, 20: 155-60.
37. Matsuo, T. Vitrectomy and silicone oil tamponade as an initial surgery for retinal detachment after acute retinal necrosis syndrome. Ocul Immunol Inflamm 2005, 13: 91-4.
38. Fisher, J.P., Lewis, M.L., Blumenkranz, M.S. et al. The acute retinal necrosis syndrome. I. Clinical manifestations. Ophthalmology 1982, 89: 1309-16.